Deutsche Bank Ag\ Century Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 19,519 shares of IPSC stock, worth $14,248. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,519

Previous 7,261 168.82%

Holding current value

$14,248

Previous $18,000 83.33%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1.44 - $3.29 $17,651 - $40,328	12,258 Added 168.82%	19,519 $33,000
Q2 2024 Aug 14, 2024	SELL	$2.46 - $4.05 $6,083 - $10,015	-2,473 Reduced 25.41%	7,261 $18,000
Q1 2024 May 15, 2024	SELL	$3.19 - $5.32 $59,834 - $99,787	-18,757 Reduced 65.83%	9,734 $40,000
Q4 2023 Feb 14, 2024	BUY	$1.28 - $3.32 $35,048 - $90,908	27,382 Added 2469.07%	28,491 $94,000
Q3 2023 Nov 09, 2023	SELL	$2.0 - $3.23 $44,940 - $72,578	-22,470 Reduced 95.3%	1,109 $2,000
Q2 2023 Aug 14, 2023	BUY	$2.91 - $3.53 $32,356 - $39,250	11,119 Added 89.24%	23,579 $74,000
Q1 2023 May 15, 2023	BUY	$3.4 - $5.11 $17,387 - $26,132	5,114 Added 69.62%	12,460 $43,000
Q4 2022 Feb 13, 2023	BUY	$4.84 - $11.58 $658 - $1,574	136 Added 1.89%	7,346 $37,000
Q3 2022 Nov 14, 2022	SELL	$8.57 - $13.1 $11,526 - $17,619	-1,345 Reduced 15.72%	7,210 $71,000
Q2 2022 Aug 11, 2022	SELL	$7.96 - $12.43 $14,312 - $22,349	-1,798 Reduced 17.37%	8,555 $72,000
Q1 2022 May 13, 2022	BUY	$11.62 - $15.92 $36,928 - $50,593	3,178 Added 44.29%	10,353 $131,000
Q4 2021 Feb 11, 2022	BUY	$13.93 - $23.62 $5,293 - $8,975	380 Added 5.59%	7,175 $114,000
Q3 2021 Nov 04, 2021	BUY	$20.8 - $31.93 $141,336 - $216,964	6,795 New	6,795 $171,000

Others Institutions Holding IPSC

# of Institutions

Shares Held

36.9M

Call Options Held

8.7K

Put Options Held

10.2K

View Full List

About Century Therapeutics, Inc.

Ticker IPSC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,881,800
Market Cap $43M
Description
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...

More about IPSC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account